share_log

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Ballantyne Charles Evan

Apr 12, 2023 17:36
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more